Last 12 months
Inside the activity.
9 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 1 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2023 Filed Jun 5, 2023 18:14 UTC |
Iskra Michael S.EVP & CCO
|
Tax withholdingCommon Stock | 1,839 | $85.65 | $157,510.35 |
DisclosureSEC source: 0001209191-23-034579 · doc4.xml · nonDerivative · entry 2 Iskra Michael S. · CIK 0001839432 · EVP & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,907 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 18:14 UTC |
Iskra Michael S.EVP & CCO
|
GrantCommon Stock | 3,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034579 · doc4.xml · nonDerivative · entry 1 Iskra Michael S. · CIK 0001839432 · EVP & CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,746 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:14 UTC |
Brandy LouiseSVP, Chief Information Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 620 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034577 · doc4.xml · derivative · entry 3 Brandy Louise · CIK 0001978061 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,240 Underlying: Common Stock · 620 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 620 shares vested on June 1, 2023; the remaining 1,240 shares will vest in equal installments on June 1, 2024 and June 1, 2025. F4 · derivative.expiration_date: 620 shares vested on June 1, 2023; the remaining 1,240 shares will vest in equal installments on June 1, 2024 and June 1, 2025. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:14 UTC |
Brandy LouiseSVP, Chief Information Officer
|
Tax withholdingCommon Stock | 215 | $85.65 | $18,414.75 |
DisclosureSEC source: 0001209191-23-034577 · doc4.xml · nonDerivative · entry 2 Brandy Louise · CIK 0001978061 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 878 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 22:14 UTC |
Brandy LouiseSVP, Chief Information Officer
|
GrantCommon Stock | 620 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034577 · doc4.xml · nonDerivative · entry 1 Brandy Louise · CIK 0001978061 · SVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,093 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 3. Read SEC document |
| May 27, 2023 Filed May 31, 2023 20:05 UTC |
Smith Christopher MDirector
|
Tax withholdingCommon Stock | 1,225 | $85.54 | $104,786.50 |
DisclosureSEC source: 0001209191-23-033101 · doc4.xml · nonDerivative · entry 1 Smith Christopher M · CIK 0001436707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,329 F1 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the vesting of previously granted restricted stock awards. Read SEC document |
| May 25, 2023 Filed May 30, 2023 16:05 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032859 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 840 Underlying: Common Stock · 420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 420 shares vested on May 25, 2023; the remaining 840 shares will vest in equal installments on May 25, 2024 and May 25, 2025. F4 · derivative.expiration_date: 420 shares vested on May 25, 2023; the remaining 840 shares will vest in equal installments on May 25, 2024 and May 25, 2025. Read SEC document |
| May 25, 2023 Filed May 30, 2023 16:05 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 146 | $84.72 | $12,369.12 |
DisclosureSEC source: 0001209191-23-032859 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,575 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 25, 2023 Filed May 30, 2023 16:05 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032859 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,721 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:22 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 293 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032336 · doc4.xml · derivative · entry 3 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293 Underlying: Common Stock · 293 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:22 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 978 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032336 · doc4.xml · derivative · entry 2 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 978 Underlying: Common Stock · 978 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 24, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:22 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032336 · doc4.xml · derivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,416 Underlying: Common Stock · 2,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:21 UTC |
Smith Christopher MDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032333 · doc4.xml · derivative · entry 3 Smith Christopher M · CIK 0001436707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80 Underlying: Common Stock · 80 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:21 UTC |
Smith Christopher MDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032333 · doc4.xml · derivative · entry 2 Smith Christopher M · CIK 0001436707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402 Underlying: Common Stock · 402 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 24, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:21 UTC |
Smith Christopher MDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032333 · doc4.xml · derivative · entry 1 Smith Christopher M · CIK 0001436707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,416 Underlying: Common Stock · 2,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:18 UTC |
BUECHLER KENNETH FDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032324 · doc4.xml · derivative · entry 3 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 535 Underlying: Common Stock · 535 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:18 UTC |
BUECHLER KENNETH FDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 1,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032324 · doc4.xml · derivative · entry 2 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,783 Underlying: Common Stock · 1,783 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 24, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:18 UTC |
BUECHLER KENNETH FDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032324 · doc4.xml · derivative · entry 1 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,416 Underlying: Common Stock · 2,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:20 UTC |
POLAN MARY LAKE PH DDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 241 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032328 · doc4.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241 Underlying: Common Stock · 241 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:20 UTC |
POLAN MARY LAKE PH DDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032328 · doc4.xml · derivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 805 Underlying: Common Stock · 805 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 24, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:20 UTC |
POLAN MARY LAKE PH DDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032328 · doc4.xml · derivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,416 Underlying: Common Stock · 2,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:20 UTC |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 109 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032329 · doc4.xml · derivative · entry 3 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109 Underlying: Common Stock · 109 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:20 UTC |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 546 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032329 · doc4.xml · derivative · entry 2 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 546 Underlying: Common Stock · 546 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 24, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:20 UTC |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032329 · doc4.xml · derivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,416 Underlying: Common Stock · 2,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:22 UTC |
Strobeck MatthewDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032335 · doc4.xml · derivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,416 Underlying: Common Stock · 2,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:18 UTC |
Dilsaver Evelyn SDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032325 · doc4.xml · derivative · entry 3 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80 Underlying: Common Stock · 80 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:18 UTC |
Dilsaver Evelyn SDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032325 · doc4.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402 Underlying: Common Stock · 402 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 24, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:18 UTC |
Dilsaver Evelyn SDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032325 · doc4.xml · derivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,416 Underlying: Common Stock · 2,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:19 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Premium) · Derivative | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032327 · doc4.xml · derivative · entry 3 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310 Underlying: Common Stock · 310 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:19 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Converted) · Derivative | 1,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032327 · doc4.xml · derivative · entry 2 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,035 Underlying: Common Stock · 1,035 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, May 24, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:19 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032327 · doc4.xml · derivative · entry 1 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,416 Underlying: Common Stock · 2,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. Read SEC document |
| May 24, 2023 Filed May 26, 2023 00:23 UTC |
Wilkins Joseph D Jr.Director
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032338 · doc4.xml · derivative · entry 1 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,416 Underlying: Common Stock · 2,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on May 24, 2024. F2 · derivative.expiration_date: The restricted stock units vest on May 24, 2024. Read SEC document |
| May 18, 2023 Filed May 22, 2023 20:08 UTC |
Strobeck MatthewDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031413 · doc4.xml · derivative · entry 6 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 85 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F5 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2023 Filed May 22, 2023 20:08 UTC |
Strobeck MatthewDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031413 · doc4.xml · derivative · entry 5 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F5 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 18, 2023 Filed May 22, 2023 20:08 UTC |
Strobeck MatthewDirector
|
GrantCommon Stock | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031413 · doc4.xml · nonDerivative · entry 2 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,182 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 18, 2023 Filed May 22, 2023 20:08 UTC |
Strobeck MatthewDirector
|
GrantCommon Stock | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-031413 · doc4.xml · nonDerivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,097 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:22 UTC |
WIDDER KENNETH JDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029934 · doc4.xml · derivative · entry 4 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:22 UTC |
WIDDER KENNETH JDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029934 · doc4.xml · derivative · entry 3 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:22 UTC |
WIDDER KENNETH JDirector
|
GrantCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029934 · doc4.xml · nonDerivative · entry 2 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,049 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:22 UTC |
WIDDER KENNETH JDirector
|
GrantCommon Stock | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029934 · doc4.xml · nonDerivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,734 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:20 UTC |
BUECHLER KENNETH FDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029929 · doc4.xml · derivative · entry 4 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 485 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:20 UTC |
BUECHLER KENNETH FDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 1,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029929 · doc4.xml · derivative · entry 3 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:20 UTC |
BUECHLER KENNETH FDirector
|
GrantCommon Stock | 485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029929 · doc4.xml · nonDerivative · entry 2 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,390 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:20 UTC |
BUECHLER KENNETH FDirector
|
GrantCommon Stock | 1,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029929 · doc4.xml · nonDerivative · entry 1 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,905 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:21 UTC |
POLAN MARY LAKE PH DDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 262 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029931 · doc4.xml · derivative · entry 5 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 262 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:21 UTC |
POLAN MARY LAKE PH DDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029931 · doc4.xml · derivative · entry 4 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F3 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:21 UTC |
POLAN MARY LAKE PH DDirector
|
GrantCommon Stock | 262 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029931 · doc4.xml · nonDerivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,437 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:21 UTC |
POLAN MARY LAKE PH DDirector
|
GrantCommon Stock | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029931 · doc4.xml · nonDerivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,175 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:21 UTC |
Strobeck MatthewDirector
|
Exercise / conversionRestricted Stock Units (Premium) · Derivative | 262 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029932 · doc4.xml · derivative · entry 6 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 262 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F5 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
| May 14, 2023 Filed May 16, 2023 22:21 UTC |
Strobeck MatthewDirector
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029932 · doc4.xml · derivative · entry 5 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. F5 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.